Everest Group (EG) · Stock analysis
Is Everest Group Stock Cheap or Expensive Right Now?
By Quotelinks ·

Trading at a trailing price-to-earnings ratio of 8.8x, Everest Group, Ltd. stands out with valuation multiples that sit well below broad industry benchmarks. Shares of the reinsurance company last closed at $421.96 on November 19, 2026, representing a market capitalization of $15.60 billion. This multiple places the stock at a 37.9% discount to the median financial services peer, even after delivering a year-to-date return of 26.6% and a one-year return of 38.2%. Both price performances substantially beat the S&P 500, as tracked by SPY, which gained 5.8% year to date and 9.2% over the past year.
The valuation discount also extends to the company's historical standards and forward expectations. The current trailing P/E reflects a 21.7% discount to its own median over the nine fiscal year-ends shown. Furthermore, the forward price-to-earnings ratio drops to 6.9x, and the price-to-sales multiple is 1.0x, representing a 69.3% discount to the sector median. For investors assessing whether the stock is expensive or cheap, the low multiples reflect a modest PEG ratio of 0.97 alongside recent quarterly top-line contraction of 14.4%.
How Do Multiples Compare With the Sector and S&P 500?
Everest Group trades at a substantial discount compared with both its sector peers and the broader market. The stock's trailing P/E ratio of 8.8x compares to a median of 14.2x for the median S&P 500 financial services stock. Looking across the wider index, the median S&P 500 stock trades at a trailing earnings multiple of 23.3x. In relative terms, the company trades at a 37.9% discount to its financial sector peers, reflecting a much lower price tag relative to its $1.89 billion in trailing twelve-month net income.
A similar gap appears when looking at forward earnings expectations. The stock's forward P/E ratio is 6.9x, whereas the sector median forward P/E is 12.8x. This dynamic keeps the stock priced below standard sector multiples on future earnings as well. Additionally, the sector median EV to EBITDA multiple sits at 15.8x. With a PEG ratio of 0.97, the company's valuation multiple remains low relative to projected growth rates.
Revenue-based multiples tell an identical story of valuation differences. Shares trade at a price-to-sales multiple of 1.0x based on trailing twelve-month revenue of $16.16 billion. By comparison, the median S&P 500 financial services stock trades at a price-to-sales multiple of 3.1x. This difference represents a 69.3% discount to the sector median, underscoring that investors pay less per dollar of revenue for the reinsurer than for typical peers in the sector.
Wall Street opinions reflect this low-multiple profile alongside limited upside to consensus targets. A total of 17 analysts track the company, maintaining a mean price target of $425.25. Compared to the last close of $421.96, that target implies an upside of 0.8%. Investors also collect a dividend yield of 1.91% while holding shares that trade near their 52-week high of $433.00, well above the 52-week low of $304.99.
How Do Multiples Compare With Historical Fiscal Year-Ends?
Today's trailing multiple of 8.8x sits noticeably below the stock's historical median of 11.3x across the fiscal year-ends shown. Over the nine-year period from 2017 through 2025, the trailing P/E reached a low of 5.8x at the close of 2023 and a high of 100.1x at the close of 2018. The current multiple represents a 21.7% discount to that historical median, matching the exact 8.8x multiple recorded at fiscal year-end on December 31, 2025, when the stock closed at $339.35.
Examining the earlier periods reveals meaningful variation in how earnings have been valued. On December 31, 2017, the stock closed at $221.26 with a trailing P/E of 18.9x and a price-to-sales ratio of 1.4x. One year later, on December 31, 2018, the shares closed at $217.76 with an elevated P/E of 100.1x and a 1.2x price-to-sales ratio. By December 31, 2019, the share price rose to $276.84, bringing the P/E back down to 11.1x alongside a price-to-sales ratio of 1.4x.
The following years maintained lower valuation figures overall. At fiscal year-end on December 31, 2020, shares closed at $234.09, which corresponded to an 18.1x P/E and a 1.0x price-to-sales multiple. A year later, on December 31, 2021, the close of $273.92 produced a trailing P/E of 7.8x and a 1.0x price-to-sales ratio. Valuation expanded again by December 31, 2022, when shares closed at $331.27 with a 21.6x P/E and a 1.1x price-to-sales multiple.
Over the most recent fiscal years, multiples settled into single digits and low double digits. On December 31, 2023, the stock finished at $353.58 with the period low P/E of 5.8x. At the close of 2024 on December 31, 2024, the price stood at $362.46, delivering an 11.3x P/E and a 0.9x price-to-sales ratio. A year later on December 31, 2025, shares closed at $339.35 with a price-to-sales multiple of 0.8x. Across all nine years shown, the price-to-sales multiple stayed tightly bounded between a low of 0.8x and a high of 1.4x, while the median price-to-earnings ratio across the period stood at 11.3x.
What Growth and Profitability Sit Behind the Valuation?
Behind the company's discounted multiples lies a combination of solid margins and mixed top-line performance. Everest Group generated $16.16 billion in trailing twelve-month revenue, producing a net margin of 11.7% and net income of $1.89 billion. Over a longer horizon, the company expanded its top line at a three-year revenue growth rate of 13.1% per year. These operational figures are supported by an organization with 3,060 employees operating in the insurance and reinsurance industry.
Recent quarters show a notable divergence between sales and net earnings. In the latest quarter, revenue fell 14.4% year over year. Despite that top-line drop, earnings per share growth in the latest quarter remained positive at 0.5% year over year. Over the trailing twelve months, the business generated $16.16 billion in revenue and $1.89 billion in net income, supporting a net margin of 11.7%. That steady profitability sits alongside longer-term expansion, with revenue growing 13.1% per year over the last three years.
Future earnings expectations also present an optimistic contrast to recent sales trends. Consensus estimates project EPS growth of 12.4% for the next fiscal year. This forecast supports the lower forward P/E multiple of 6.9x, which also sits well below the sector median forward P/E of 12.8x. At the same time, the stock trades at a PEG ratio of 0.97. For investors weighing profitability against valuation, projected double-digit earnings growth sits alongside a stock that has experienced lower market volatility, evidenced by a beta of 0.22.
Longer-term share performance highlights where the stock has lagged broad market gains over multiple years. While the stock gained 38.2% over the trailing one-year period, its three-year total return was 13.7%. Over that same three-year stretch, the S&P 500 achieved a total return of 64.7%. This multi-year performance gap illustrates why the shares continue to change hands at single-digit earnings multiples despite strong recent 12-month momentum.
Investors evaluating Everest Group will want to watch whether upcoming quarterly results can reverse the latest quarter's 14.4% revenue decline while sustaining the trailing net margin of 11.7%. Future reports will also reveal whether the business stays on track to hit the estimated 12.4% EPS growth for next fiscal year. With shares trading at $421.96, close to the 52-week high of $433.00 and just below the 17-analyst mean price target of $425.25, the realization of projected earnings growth will determine whether the stock stays near its forward P/E of 6.9x.
Figures as of November 19, 2026. For information only, not investment advice.